Legal & General Group
ABMD

Legal & General Group’s Abiomed Inc ABMD Stock Holding History

Legal & General Group’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-360,162
Closed -$88.5M – 3450
2022
Q3 		$88.5M Sell
360,162
-15,953
-4% -$4.31M 0.03% 488
2022
Q2 		$93.1M Sell
376,115
-12,263
-3% -$3.31M 0.03% 505
2022
Q1 		$129M Buy
388,378
+24,911
+7% +$7.67M 0.04% 457
2021
Q4 		$131M Sell
363,467
-2,586
-0.7% -$874K 0.04% 463
2021
Q3 		$119M Buy
366,053
+5,762
+2% +$1.95M 0.04% 485
2021
Q2 		$112M Buy
360,291
+69,825
+24% +$21.4M 0.04% 502
2021
Q1 		$92.6M Buy
290,466
+5,171
+2% +$1.65M 0.03% 530
2020
Q4 		$92.5M Buy
285,295
+3,994
+1% +$1.1M 0.04% 501
2020
Q3 		$77.9M Sell
281,301
-1,433
-0.5% -$413K 0.03% 485
2020
Q2 		$68.3M Sell
282,734
-5,313
-2% -$1.07M 0.03% 500
2020
Q1 		$41.8M Buy
288,047
+16,392
+6% +$2.72M 0.02% 560
2019
Q4 		$46.3M Buy
271,655
+17,110
+7% +$3.17M 0.02% 619
2019
Q3 		$45.3M Buy
254,545
+872
+0.3% +$188K 0.02% 600
2019
Q2 		$66.1M Buy
253,673
+2,331
+0.9% +$618K 0.04% 510
2019
Q1 		$71.8M Buy
251,342
+56,433
+29% +$18.8M 0.04% 471
2018
Q4 		$63.4M Buy
194,909
+27,735
+17% +$9.63M 0.05% 412
2018
Q3 		$75.2M Buy
167,174
+104,583
+167% +$41.2M 0.05% 392
2018
Q2 		$25.6M Buy
62,591
+2,096
+3% +$759K 0.02% 659
2018
Q1 		$17.6M Buy
60,495
+19,926
+49% +$5.05M 0.01% 730
2017
Q4 		$7.6M Buy
40,569
+4,254
+12% +$794K 0.01% 882
2017
Q3 		$6.12M Buy
36,315
+4,416
+14% +$668K ﹤0.01% 936
2017
Q2 		$4.57M Buy
31,899
+6,520
+26% +$876K ﹤0.01% 1032
2017
Q1 		$3.18M Buy
25,379
+13,999
+123% +$1.62M ﹤0.01% 1202
2016
Q4 		$1.28M Buy
11,380
+6,358
+127% +$737K ﹤0.01% 1647
2016
Q3 		$645K Buy
5,022
+34
+0.7% +$4.07K ﹤0.01% 1586
2016
Q2 		$545K Sell
4,988
-5,027
-50% -$500K ﹤0.01% 1316
2016
Q1 		$935K Buy
10,015
+2,019
+25% +$170K ﹤0.01% 1157
2015
Q4 		$728K Buy
7,996
+384
+5% +$32.6K ﹤0.01% 1238
2015
Q3 		$690K Buy
7,612
+259
+4% +$22.8K ﹤0.01% 1218
2015
Q2 		$480K Buy
7,353
+281
+4% +$18.7K ﹤0.01% 1324
2015
Q1 		$514K Buy
7,072
+1,211
+21% +$65.7K ﹤0.01% 1281
2014
Q4 		$227K Hold
5,861
– – ﹤0.01% 1504
2014
Q3 		$147K Buy
+5,861
New +$148K ﹤0.01% 1661

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Legal & General Group's ABMD Position: Q4 2022 in Review

Legal & General Group sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 360,162 shares — an estimated $88.5M sold.

Legal & General Group first reported a position in ABMD in Q3 2014 and held it in 33 quarters. The position peaked at $131M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Legal & General Group reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Legal & General Group sold 360,162 Abiomed Inc shares in Q4 2022, an estimated $88.5M.
  • Legal & General Group first reported a position in Abiomed Inc in Q3 2014 and held it in 33 quarters.
  • Legal & General Group's Abiomed Inc position peaked at $131M in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Legal & General Group's 13F filing for Q4 2022, filed 14 Feb 2023.